Insiders · Profile

Hamm John M.

Chief Financial Officer at CUMBERLAND PHARMACEUTICALS. Filing since 23 Nov 2021. CIK 0001870439

Company
Date
Role
Action
Shares
Amount
Of holding
23 Nov 2021
Chief Financial Officer
Bought
3,800
$8.93K
127%
1 decision on file.